Tuesday, October 10, 2023
Following the White House’s proposal for a National Hepatitis C Elimination Plan as part of its Fiscal Year 2024 budget request to Congress, and the fact that key populations for HIV are also at high risk of HCV, Treatment Action Group organized a webinar highlighting best practices and challenges for HCV elimination with a specific focus on high-burden populations. The webinar sought to equip policymakers, clinicians, health advocates, civil society and other stakeholders with tools to better address barriers to eliminating HCV among key populations and encouraged participants to apply new insights into HCV/HIV comorbidity to their work.
Moderator: Treatment Action Group consultant, Ryan Clary
–Dr Seun Falade-Nwulia, MD and Director of the Johns Hopkins Bayview Center for substance use and infectious disease care integration
–Cesar Espinoza-Perez, a person with lived experience
–Annette Gaudino, Advocacy Coalition Manager for the Global AIDS Policy Partnership (GAPP) at AVAC
–Julio Contreras Manager, Policy & Legislative Affairs at NASTAD
–Francis S. Collins, MD, PhD, White House Lead on the National Initiative to Eliminate Hepatitis C, Former Director of NIH